You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Details for Patent: 6,503,362


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,503,362
Title: Atomizing nozzle an filter and spray generating device
Abstract:A nozzle assembly for use in atomizing and generating sprays from a fluid. The nozzle assembly includes two members, each with generally planar surfaces, that are joined together. A first set of channels is formed in the generally planar surface of a first one of the members to form, in cooperation with the generally planar surface of the second of the members, a plurality of filter passageways. A plenum chamber is formed in the first member. The plenum chamber is in fluid communication with and downstream of the plurality of filter passageways. A second set of channels is formed in the generally planar surface of the first member to form, in cooperation with the generally planar surface of the second member, a plurality of nozzle outlet passageways. These nozzle outlet passageways are in fluid communication with the plenum chamber. The nozzle outlet passageways include a plurality of nozzle outlets which are adapted to discharge a plurality of fluid jets that impinge on one another to thereby atomize a flow of fluid.
Inventor(s): Bartels; Frank (Waldbronn, DE), Bachtler; Wulf (Mainz, DE), Dunne; Stephen Terence (Suffolk, GB), Eicher; Joachim (Karlsruhe, DE), Freund; Bernhard (Gau-Algesheim, DE), Hart; William Barrie (Suffolk, GB), Lessmoellmann; Christoph (Karlsruhe, DE)
Assignee: Boehringer Ingelheim International GmbH (DE)
Application Number:09/472,169
Patent Claim Types:
see list of patent claims
Device;

Drugs Protected by US Patent 6,503,362

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,503,362

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9220505Sep 29, 1992
United Kingdom4236037Oct 24, 1992
United Kingdom9314804Jul 19, 1993

International Family Members for US Patent 6,503,362

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 183673 ⤷  Try a Trial
Austria 312669 ⤷  Try a Trial
Austria 421384 ⤷  Try a Trial
Australia 4829993 ⤷  Try a Trial
Canada 2145758 ⤷  Try a Trial
Canada 2445256 ⤷  Try a Trial
Canada 2475424 ⤷  Try a Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.